Faslodex 250mg Injection - Fulvestrant

Faslodex 250mg Injection, containing Fulvestrant (250mg), is a prescription medication used to treat certain hormone receptor-positive, HER2-negative advanced or metastatic breast cancer.

This injectable treatment works by blocking the effects of estrogen, a key hormone involved in tumor growth. The high dose of Fulvestrant effectively reduces estrogen levels, slowing tumor progression and potentially shrinking existing tumors.

Key Features:
* Precise dosing: Faslodex Injection provides a controlled and consistent delivery of 250mg of Fulvestrant.
* Proven efficacy: It is a leading treatment option for hormone receptor-positive breast cancer, significantly improving patient outcomes in clinical trials.
* Convenient administration: This pre-filled vial offers ease of use with a simple injection method, making it suitable for home or clinic settings.

Important Note: This medication should only be administered under the guidance of a healthcare professional. A comprehensive medical assessment is necessary before initiation and ongoing monitoring by a doctor is essential to ensure optimal dosage and management of potential side effects.